Inflammation &
Immune Monitoring
Chronic, low-grade inflammation — or "inflammaging" — is a primary driver of tissue degeneration, metabolic syndrome, and cellular aging. Transcriptomics allows us to monitor inflammatory cytokines and resolution pathways at the transcription level.
Quantifying Inflammatory Resolution
Circulating proteins like C-Reactive Protein (CRP) are commonly used to track inflammation, but they fluctuate slowly and lack tissue specificity.
Inflammation transcriptomics measures active gene transcription. By tracking the activity of NF-κB, IL-6, and anti-inflammatory genes like IL-10, we can see if an intervention is successfully dampening pro-inflammatory cascades at the transcriptional level.
This provides a sensitive, early readout of therapeutic response weeks before systemic markers reflect the shift.
Key Pathway Targets
Nuclear Factor kappa B Subunits 1 and 2
Primary transcriptional orchestrator of inflammatory cytokine cascades.
Interleukin 6
Key pro-inflammatory cytokine linked to acute and chronic systemic inflammation.
Tumor Necrosis Factor (TNF-α)
Potent inflammatory signaling cytokine implicated in tissue catabolism.
Interleukin 10
Crucial anti-inflammatory cytokine that inhibits transcription of pro-inflammatory factors.
Transforming Growth Factor Beta 1
Mediates immune tolerance, resolving active tissue inflammatory phases.
Why DNA Tells Only Half the Inflammatory Story
Your static DNA codes for variants in inflammatory cytokines, such as promoter SNPs in the TNF-α gene. These variations indicate your genetic predisposition to hyper-inflammatory states (inflammaging) and auto-immune strain, but represent potential rather than active pathology.
Transcriptomics (RNA) measures active cytokine transcription in real time. By tracking messenger RNA, we can verify whether your current lifestyle, sleep quality, or anti-inflammatory peptide therapies (such as KPV) are successfully silencing pro-inflammatory gene transcription.
Legacy Panels vs. Transcriptomics
Traditional inflammation panels rely on liver-produced marker proteins circulating in the bloodstream. Transcriptomics directly quantifies the active gene transcription driving inflammatory pathways at the source.
| Legacy Biomarker | Biological Limitation | RNA Target |
|---|---|---|
| hs-CRP | Lagging systemic liver protein; highly non-specific to tissue source. | NFKB1 |
| Erythrocyte Sed Rate (ESR) | Reflects general protein aggregation in blood; changes over weeks. | IL6 / TNF |
| Serum Cytokines | Extremely short half-lives in circulation; difficult to capture. | IL10 / TGFB1 |
The NF-κB Activation and Resolution Cascade
Inflammation is regulated by a molecular toggle. When tissues experience stress, pro-inflammatory ligands activate the transcription factor NF-κB, translocating it to the nucleus to transcribe primary cytokines. Mitigating damage requires activating counter-regulatory resolution genes.
Stress Stimulus
Pathogens, toxins, or tissue injury activate intracellular receptor tyrosine kinases.
NF-κB Translocation
Phosphorylation of IκB releases NF-κB (NFKB1) to bind promoters in the nucleus.
Cytokine Transcription
Upregulated mRNA of TNF and IL6 initiates localized immune cell recruitment.
Immune Resolution
STAT3 pathway activation stimulates anti-inflammatory IL10 to repress cytokine transcription.
Resolving Chronic Inflammaging Naturally
These clinically validated interventions and dietary cofactors assist the body in downregulating chronic inflammatory gene networks.
EPA & DHA Omega-3 Fatty Acids
Inhibit NF-κB nuclear translocation and serve as substrate precursors for Resolvins and Protectins that actively resolve inflammation.
Bioactive Curcumin
Potent natural modulator of the IκB kinase complex, helping prevent the degradation of NF-κB's inhibitory subunit.
Sleep Optimization (HPA Regulation)
Prevents the nocturnal cortisol spikes that exhaust glucocorticoid receptors, helping maintain natural systemic anti-inflammatory transcription.
Vagus Nerve Stimulation (ACh Pathway)
Activates the cholinergic anti-inflammatory pathway, where acetylcholine binding to macrophages directly suppresses cytokine production.
Modulating Immune Pathways
The following therapies primarily modulate the Inflammation & Immune dimension on the dashboard.
KPV
Upregulates anti-inflammatory cytokines (IL-10, TGF-β1) while suppressing active NF-κB signaling.
HRT
Estradiol and progesterone combinations regulate macrophage activation and downregulate inflammatory cytokine transcription.
GLP-1 receptor agonists
Reduces systemic inflammaging pathways, downregulating IL-6 and TNF-α at the transcriptional level.
Deployable Inflammatory Assays
Biomeme's platform delivers rapid, quantitative profiling of inflammatory transcripts in under 15 minutes, bridging the gap between point-of-care clinics and high-throughput CLIA lab processing.
Curious how we measure this?
Learn about the foundational science of Transcriptomics and how Biomeme brings molecular profiling to the point of need.
Ready to Learn More?
Explore how Biomeme's capabilities are being deployed across the Wellness landscape.